SGK1 and nervous system disorder: As the study develops in depth, further elucidation of the molecular mechanism of SGK1 in various neurological diseases, as well as strengthening the development of biopharmaceuticals and molecular inhibitors targeting SGK1, can provide important theoretical basis and therapeutic means for the treatment of related clinical diseases.